))
Interview with Drs. Mary Beth Harler and Robert Plenge from Bristol Myers Squibb
Manage episode 286011555 series 2872650
Innhold levert av Maria C. Freire, Ph.D. and Maria C. Freire. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Maria C. Freire, Ph.D. and Maria C. Freire eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Dr. Freire hosts an engaging and informative conversation with two scientists from Bristol Myers Squibb: Dr. Mary Beth Harler and Dr. Robert Plenge. Learn how treatments for COVID-19 are addressed along the continuum from initial work in the lab to patient care. Drs. Freire, Harler and Plenge also discuss the importance of looking at the biology of this virus to identify the best treatment options.
Dr. Mary Beth Harler is Senior Vice President, Head of Immunology & Fibrosis Development, Global Drug Development and Dr. Robert Plenge is Senior Vice President, Research & Early Development and Head of the Immunology, Cardiovascular, Fibrosis, and Global Health Thematic Research Center team of Bristol Myers Squibb.
7 episoder
Del
